Highlights Codexis, Inc.

Equities

CDXS

US1920051067

Market Closed - Nasdaq Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
3.1 ^USD	+2.99%		+5.44%	+1.64%

05-30	Cantor Fitzgerald Starts Codexis With Overweight Rating, $11 Price Target	MT
05-14	Codexis, Inc. Presents Enzymatic Synthesis Data at TIDES USA Annual Meeting and Launches RNA Ligase Screening and Optimization Services	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Codexis, Inc. Presents Enzymatic Synthesis Data at TIDES USA Annual Meeting and Launches RNA Ligase Screening and Optimization Services	05-14	CI
Earnings Flash (CDXS) CODEXIS Posts Q1 Revenue $17.1M, vs. Street Est of $13.3M	05-02	MT
Codexis, Inc. Reiterates Financial Guidance for the Fiscal 2024	05-02	CI
Codexis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
Earnings Flash (CDXS) CODEXIS Reports Q4 Revenue $26.6M, vs. Street Est of $18.9M	02-28	MT
Codexis, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-28	CI
Codexis Shares Up 31% on Roche Licensing Agreement	02-27	DJ
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche	02-26	CI
Roche Sequencing Solutions, Inc. entered into an agreement to acquire Global license of double-stranded DNA from Codexis, Inc.	02-25	CI
SeqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting	02-01	CI
Codexis, Inc. Announces Purchase Agreement with Nestle Health Science for Cdx-7108	12-27	CI
Codexis Assigns Interests in Potential Exocrine Pancreatic Insufficiency Treatment to Nestle Health Science	12-27	MT
Federal Reserve Outlook Pushes Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday	12-14	MT
Codexis Signs Exclusive License Agreement With Aldevron for Codex HiCap RNA Polymerase; Shares Surge Premarket	12-14	MT
Codexis Signs Exclusive License Agreement With Aldevron for Codex HiCap RNA Polymerase	12-13	MT
Codexis, Inc. and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase	12-13	CI
Aldevron, LLC entered into an agreement to acquire global exclusive license for Codex® HiCap RNA Polymerase from Codexis, Inc..	12-12	CI
Codexis, Inc. Reiterates Earnings Guidance for the Year 2023	11-02	CI
Earnings Flash (CDXS) CODEXIS Posts Q3 Revenue $9.3M, vs. Street Est of $10M	11-02	MT
Codexis, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Codexis, Inc.

Equities

CDXS

US1920051067

Highlights

Filters